🟡Relating to the certificate of medical examination for chemical dependency and the duration of court-ordered treatment for a person with a chemical dependency.
HB 171
🟡 HB 171: Standardized Rules for Court-Ordered Drug Treatment
What it says it does:
HB 171 sets uniform state rules for when a court can order someone into treatment for chemical dependency. It requires a medical certificate from a doctor, defines what that certificate must include, and sets treatment to last between 30 and 90 days. It also allows a doctor or facility administrator to release someone early if they no longer meet the criteria.
What it actually changes:
It replaces vague local standards with statewide requirements. It shortens the previous proposed minimum stay from 60 days to 30 but still sets a mandatory floor. It moves oversight of treatment facility approvals to the Health and Human Services Commission and applies the same rules to adult civil commitments, misdemeanor diversion, and juvenile cases.
Who is pushing for it:
NAMI Texas, the Association of Substance Abuse Programs, and the Statutory Probate Judges of Texas supported the bill. Individual supporters in the witness lists include Christine Busse, Duane Galligher, and Tracy Clarke.
Who benefits:
Approved treatment centers gain predictable referral flows and longer guaranteed stays. HHSC gains control over which facilities are eligible for court referrals. Judges gain consistent standards that reduce appeals risk.
Who gets left out or exposed:
People ordered to treatment lose flexibility for short-term care or rapid release. Small or rural facilities that are not approved by HHSC may lose access to court-ordered referrals. Civil liberties advocates may find it harder to challenge commitment length.
Why this matters long term:
The bill creates consistency across the state, but it also concentrates control. HHSC becomes the central approval body, which could limit regional access if too few facilities are approved. It adds predictability but also raises the risk of longer confinement without required review points.
What to watch next:
Watch how HHSC writes and enforces its approval rules and whether any reporting is required on early releases or average stay lengths. Regional access gaps could grow if approval criteria favor large treatment networks. Future bills may build on this model and extend HHSC control to other treatment or diversion programs.
Bottom line:
HB 171 was written as a consistency and safety measure, but it shifts power to state administrators and larger treatment providers. Without required periodic reviews or transparent approval data, the people most affected, patients and families, have less say in how long they stay and where they go.
#HB171 #TexasPolicy #TexasHealth #CourtReform #WatchTheRules